3D-printed simulator for nasopharyngeal swab collection for COVID-19

Infect Dis Now. 2022 May;52(3):138-144. doi: 10.1016/j.idnow.2022.02.002. Epub 2022 Feb 8.

Abstract

Objectives: Diagnosis of COVID-19 is essential to prevent the spread of SARS-CoV-2. Nasopharyngeal swabs (NPS) remain the gold standard in screening, although associated with false negative results (up to 30%). We developed a 3D simulator of the nasal and pharyngeal cavities for the learning and improvement of NPS collection.

Patients and methods: Simulator training sessions were carried out in 11 centers in France. A questionnaire assessing the simulator was administered at the end of the sessions. The study population included both healthcare workers (HCW) and volunteers from the general population.

Results: Out of 589 participants, overall satisfaction was scored 9.0 [8.9-9.1] on a scale of 0 to 10 with excellent results in the 16 evaluation items of each category (HCWs and general population, NPS novices and experienced). The simulator was considered very realistic (95%), easy to use (97%), useful to understand the anatomy (89%) and NPS sampling technique (93%). This educational tool was considered essential (93%). Participants felt their future NPS would be more reliable (72%), less painful (70%), easier to perform (88%) and that they would be carried out more serenely (90%). The mean number of NPS conducted on the simulator to feel at ease was two; technical fluency with the simulator can thus be acquired quickly.

Conclusion: Our simulator, whose 3D printing can be reproduced freely using a permanent open access link, is an essential educational tool to standardize the learning and improvement of NPS collection. It should enhance virus detection and thus contribute to better pandemic control.

Keywords: 3D simulator; COVID-19; Coronavirus; Nasopharyngeal swab.

MeSH terms

  • COVID-19 Testing / instrumentation
  • COVID-19 Testing / methods*
  • COVID-19* / diagnosis
  • Humans
  • Nasopharynx
  • Printing, Three-Dimensional*
  • SARS-CoV-2